Concepedia

Author

Christian Baglini

Harvard University

Also Known As

C. Baglini, Christian Baglini, Christian V. Baglini

52

Publications

783

Citations

6

H-Index

19

Concepts

All Affiliations

Harvard UniversityBrigham and Women's HospitalBeth Israel Deaconess Medical CenterUniversity of Pittsburgh Medical CenterMassachusetts General Hospital
CB

About

Christian Baglini is an author at Harvard University specializing in medicine, radiation oncology, and cancer cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

199

2

Health Sciences

1

1

31

3

Natural Sciences

1

1

155

4

Biochemistry

1

1

155

5

Cell Biology

1

1

13

Christian Baglini

×

6

Publications

768

Citations

6

H-Index

YearCitations

Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer

Janet E. Murphy, Jennifer Y. Wo, David P. Ryan,

JAMA Oncology

2019

484

mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability

Alexander J. Valvezan, Marc Turner, Amine Belaïd,

Cancer Cell

2017

155

p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis

Hilaire C. Lam, Christian Baglini, Alicia Llorente Lope,

Cancer Research

2017

62

Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study

Jennifer Y. Wo, John P. Plastaras, James M. Metz,

International Journal of Radiation Oncology*Biology*Physics

2019

31

Rapamycin-induced miR-21 promotes mitochondrial homeostasis and adaptation in mTORC1 activated cells

Hilaire C. Lam, Heng-Jia Liu, Christian Baglini,

Oncotarget

2017

23

Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ)

Heng-Jia Liu, Hilaire C. Lam, Christian Baglini,

Oncogene

2019

13

Page 1